Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs

Aduhelm for Alzheimer’s Discontinued. Is Leqembi Any Better?

February 8, 2024 No Comments

Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.

Leqembi: An Alzheimer’s Drug Worth Rooting For?

November 16, 2023 No Comments

At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease. Only five Alzheimer’s treatments have been approved by the FDA up until a decade ago, and this is only the second to address the progression of the disease.

Adlarity has 7 Advantages over Donepezil Tablets

October 22, 2023 No Comments

FDA-approved ADLARITY is the once-weekly donepezil patch. See how it compares to donepezil / Aricept / Ebixa tablets for Alzheimer’s.

ARIA in Lacanemab, Donanemab and Aduhelm

September 8, 2023 No Comments

A neuroradiologist at the Mayo Clinic in Jacksonville, FL warns that increased use of monoclonal antibody treatment for Alzheimer’s has also led to the discovery of amyloid-related imaging abnormalities — ARIA. Find out more.

laboratory, test tubes, healthcare worker

A Timeline of Alzheimer’s Drug Development

September 7, 2023 No Comments

The first drugs for Alzheimer’s disease emerged in the 1990s, but since then there has been a wave of clinical trial failures, major companies pulling resources from neuroscience R&D, and progress.

woman wearing yellow and pink floral dress wahing carrots

Prescribing Lecanemab in Real Life

July 28, 2023 1 Comment

Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.

Lilly’s Donanemab: The 3rd New Alzheimer’s Drug

July 21, 2023 No Comments

Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.

New Alzheimer’s Drug Lecanemab: High price tag, Moderate warnings

July 14, 2023 No Comments

The FDA has approved generic lecanemab (brand name Leqembi^®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

Leqembi Medication for Alzheimer's (Generic: Lecanemab)

Alzheimer’s Drug Leqembi Gets Full FDA and MEDICARE Approval

July 7, 2023 No Comments

First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

FDA Unanimously Votes Leqembi Benefits Alzheimer’s

June 11, 2023 1 Comment

The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s

two blue beach chairs near body of water

400,000 People Show Delaying Retirement Delays Dementia

April 16, 2026

Delaying retirement can delay dementia in a big way. Learn why.

Vitamin D Fends Off Dementia

April 16, 2026

PREVENTION VIDEO + ARTICLE:
Researchers in Australia have discovered that taking sufficient Vitamin D can help stop Alzheimer’s. Learn more.

A man, standing, a woman sitting and a doll on a table.

One Man Rising Above His Alzheimer’s

April 15, 2026

Scott Russell is living well with his Alzheimer’s. See how he has stayed active in his community, even starting a manageable home business.

Most Popular Stories

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

“I’ve Got You Under My Skin,” By Dad with Dementia & Son

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

Is Alzheimer’s Catchy?

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.